Fig. 1From: Eculizumab therapy on a patient with co‐existent lupus nephritis and C3 mutation‐related atypical haemolytic uremic syndrome: a case reportClinical course and key events. Abbreviations: E, eculizumab; IV, intravenous; PLT, platelet; UACR, urine albumin-to-creatinine ratioBack to article page